SCHEMBL6834152

SCHEMBL6834152

CCCn1c(C(=O)Nc2ccc(Br)cc2C(=O)O)cc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
TSHR P16473 2/20 0.49
HTT P42858 1/20 0.49
AKR1C2 P52895 3/20 0.49
AKR1C1 Q04828 3/20 0.49
POLB P06746 2/20 0.49
AKR1C4 P17516 1/20 0.49
AKR1C3 P42330 1/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
CNR2 P34972 1/20 0.45
KDM1A O60341 1/20 0.44
RCOR1 Q9UKL0 1/20 0.44
MAPT P10636 2/20 0.44
ABL1 P00519 1/20 0.44
RIN1 Q13671 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP1A2 P05177 1/20 0.44
KDM4E B2RXH2 1/20 0.43
USP2 O75604 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6834157 0.94 POLB (0.53) ALDH1A1TSHRHTTAKR1C2AKR1C1
SCHEMBL6833056 0.93 CNR2 (0.52) ALDH1A1TSHRHTTAKR1C2AKR1C1
SCHEMBL6830750 0.90 HDAC3 (0.49) ALDH1A1TSHRHTTAKR1C2AKR1C1
SCHEMBL6834054 0.87 ALDH1A1 (0.49) ALDH1A1TSHRHTTAKR1C2AKR1C1
SCHEMBL6834681 0.87 CNR2 (0.48) ALDH1A1TSHRHTTAKR1C2AKR1C1
SCHEMBL6830678 0.86 AKR1C2 (0.48) ALDH1A1TSHRHTTAKR1C2AKR1C1
SCHEMBL6835816 0.86 CCR2 (0.58) AKR1C2AKR1C1AKR1C4AKR1C3MEN1
SCHEMBL6835781 0.85 MCL1 (0.55) AKR1C2AKR1C1AKR1C4AKR1C3MEN1
SCHEMBL6834434 0.85 CNR2 (0.50) ALDH1A1TSHRHTTPOLBCNR2
SCHEMBL6834189 0.84 AKR1C2 (0.48) ALDH1A1TSHRHTTAKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US claimed
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 ALDH1A1 170/4885TSHR 3622/4885HTT 1599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.